Registered entities
Libra Therapeutics, Inc.
Reg. No. 84-5010331United States
Innovation
5 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace accelerating. Cited 66 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
Social engagement
Social engagement: 1.5K social following, 2 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 100% |
Recent activity
15 Oct 2025
Leadership hire
Chief Scientific Officer